Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Organisation › Details

Bone Therapeutics (Group)

Bone Therapeutics is a leading biotechnology company specializing in the development of cell therapy products intended for bone fracture repair and fracture prevention. The current standard-of-care in this field involves major surgeries and long recovery periods. To overcome these problems, Bone Therapeutics is developing a range of innovative regenerative products containing osteoblastic/bone-forming cells, administrable via a minimally invasive percutaneous technique; a unique proposition in the market. PREOB®, Bone Therapeutics’ autologous bone cell product, is currently in pivotal Phase IIB/III clinical studies for two indications: osteonecrosis and non-union fractures, and in Phase II for severe osteoporosis. ALLOB®, its allogeneic “off-the-shelf” bone cell product, is in Phase II for the treatment of delayed-union fractures and spinal fusion procedures. The Company also runs preclinical research programs and develops novel product candidates. Founded in 2006, Bone Therapeutics is headquartered in Gosselies (South of Brussels, Belgium). Bone Therapeutics’ regenerative products are manufactured to the highest GMP standards and are protected by a rich IP estate covering 11 patent families. *

 

Period Start 2006-01-01 established
Products Industry cell therapy
  Industry 2 PREOB® autologous bone cell therapy product
Persons Person Lienard, Thomas (Bone Therapeutics 201610– Interim CEO joined 201511– as CBO before Lundbeck + Lilly + McKinsey)
  Person 2 Goemaere, Wim (Bone Therapeutics 201309– CFO before Devgen CFO + VIB CFO)
     
Region Region Gosselies
  Country Belgium
  Street 7 Rue Auguste Piccard
  City 6041 Gosselies
  Tel +32-2-529-5990
    Address record changed: 2018-07-24
     
Basic data Employees C: 51 to 100 (2017-12-31)
  Currency EUR
  Annual sales 4,213,000 (income, operating, total, consolidated (2017) 2017-12-31)
  Profit -12,769,000 (2017-12-31)
  Cash 8,411,000 (2017-12-31)
     
    * Document for �About Section�: Bone Therapeutics S.A.. (11/9/15). "Press Release: Bone Therapeutics Appoints Thomas Lienard as Chief Business Officer". Gosselies.
     
   
Record changed: 2018-11-12

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Bone Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top